Gujarat Terce Laboratories Ltd vs Samrat Pharmachem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Gujarat Terce Laboratories Ltd is ₹ 32.72 as of 12 Jun 15:30 . The P/E Ratio of Gujarat Terce Laboratories Ltd changed from 22.2 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Samrat Pharmachem Ltd changed from 7.9 on March 2021 to 13.6 on March 2025 . This represents a CAGR of 11.48% over 5 years The Market Cap of Gujarat Terce Laboratories Ltd changed from ₹ 5.16 crore on March 2021 to ₹ 45.37 crore on March 2025 . This represents a CAGR of 54.46% over 5 yearsThe Market Cap of Samrat Pharmachem Ltd changed from ₹ 42.02 crore on March 2021 to ₹ 96.63 crore on March 2025 . This represents a CAGR of 18.12% over 5 years The revenue of Gujarat Terce Laboratories Ltd for the Mar '26 is ₹ 11.48 crore as compare to the Dec '25 revenue of ₹ 12.42 crore. This represent the decline of -7.57% The revenue of Samrat Pharmachem Ltd for the Mar '26 is ₹ 71.47 crore as compare to the Dec '25 revenue of ₹ 63.83 crore. This represent the growth of 11.97% The ebitda of Gujarat Terce Laboratories Ltd for the Mar '26 is ₹ 0.36 crore as compare to the Dec '25 ebitda of ₹ 1.26 crore. This represent the decline of -71.43% The ebitda of Samrat Pharmachem Ltd for the Mar '26 is ₹ -1.55 crore as compare to the Dec '25 ebitda of ₹ -0.26 crore. This represent the growth of 496.15% The net profit of Gujarat Terce Laboratories Ltd changed from ₹ -0.08 crore to ₹ 0.1 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Samrat Pharmachem Ltd changed from ₹ 2.07 crore to ₹ -2.04 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Gujarat Terce Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2022 to 4.35 % on March 2025 . This represents a CAGR of 24.68% over 4 years .

About Gujarat Terce Laboratories Ltd

Gujarat Terce Laboratories Limited, incorporated in 1985, is a trusted manufacturer of high quality medication at affordable rates for the common man.
Company specialise in producing oral solid dosages, including tablets and capsules, that address various therapeutic needs. Headquartered in Ahmedabad, Gujarat, Terce offers an extensive portfolio featuring over 125 products and more than 64 well-established brands. By 1986, Terce had established its presence in Gujarat and Rajasthan with a firm footing.
In 1992, the management raised public equity to give concrete shape and listed the Company on Bombay Stock Exchange.
In same year, Company established extensive manufacturing facility at Chhatral in Gandhinagar, Gujarat.
As India heralded new leaps in the pharma sector to become a global force to reckon with by 2005, the Company closely followed the narrative with ferocious growth expanding presence in the domestic and international market.

About Samrat Pharmachem Ltd

Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta.
Since then, it envisioned to focus on lodine Derivatives as their core products.
The Company's principal activities are manufacturing and selling chemicals.
Company is a producer of pharmaceutical chemicals.
The intermediates produced are used in pharmaceutical and chemical industries.

FAQs for the comparison of Gujarat Terce Laboratories Ltd and Samrat Pharmachem Ltd

Which company has a larger market capitalization, Gujarat Terce Laboratories Ltd or Samrat Pharmachem Ltd?

Market cap of Gujarat Terce Laboratories Ltd is 25 Cr while Market cap of Samrat Pharmachem Ltd is 62 Cr

What are the key factors driving the stock performance of Gujarat Terce Laboratories Ltd and Samrat Pharmachem Ltd?

The stock performance of Gujarat Terce Laboratories Ltd and Samrat Pharmachem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gujarat Terce Laboratories Ltd and Samrat Pharmachem Ltd?

As of June 14, 2026, the Gujarat Terce Laboratories Ltd stock price is INR ₹32.72. On the other hand, Samrat Pharmachem Ltd stock price is INR ₹200.75.

How do dividend payouts of Gujarat Terce Laboratories Ltd and Samrat Pharmachem Ltd compare?

To compare the dividend payouts of Gujarat Terce Laboratories Ltd and Samrat Pharmachem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.